Cargando…

Recent Advances and Applications of Molecular Docking to G Protein-Coupled Receptors

The growing number of studies on G protein-coupled receptors (GPCRs) family are a source of noticeable improvement in our understanding of the functioning of these proteins. GPCRs are responsible for a vast part of signaling in vertebrates and, as such, invariably remain in the spotlight of medicina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartuzi, Damian, Kaczor, Agnieszka A., Targowska-Duda, Katarzyna M., Matosiuk, Dariusz
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155844/ https://www.ncbi.nlm.nih.gov/pubmed/28241450 http://dx.doi.org/10.3390/molecules22020340

Ejemplares similares

Signaling within Allosteric Machines: Signal Transmission Pathways Inside G Protein-Coupled Receptors
por: Bartuzi, Damian, et al.
Publicado: (2017)

Preferential Coupling of Dopamine D(2S) and D(2L) Receptor Isoforms with G(i1) and G(i2) Proteins—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2020)

Novel Positive Allosteric Modulators of µ Opioid Receptor—Insight from In Silico and In Vivo Studies
por: Bartuzi, Damian, et al.
Publicado: (2020)

The Universal 3D QSAR Model for Dopamine D(2) Receptor Antagonists
por: Zięba, Agata, et al.
Publicado: (2019)

Synthesis and molecular docking of novel non-competitive antagonists of GluK2 receptor
por: Kaczor, Agnieszka A., et al.
Publicado: (2014)

Allosteric modulation of dopamine D(2L) receptor in complex with G(i1) and G(i2) proteins: the effect of subtle structural and stereochemical ligand modifications
por: Żuk, Justyna, et al.
Publicado: (2022)

Comparative molecular field analysis and molecular dynamics studies of the dopamine D(2) receptor antagonists without a protonatable nitrogen atom
por: Kaczor, Agnieszka A., et al.
Publicado: (2018)

Overcoming Depression with 5-HT(2A) Receptor Ligands
por: Zięba, Agata, et al.
Publicado: (2021)

In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
por: Koszła, Oliwia, et al.
Publicado: (2020)

Allosteric Modulators of Dopamine D(2) Receptors for Fine-Tuning of Dopaminergic Neurotransmission in CNS Diseases: Overview, Pharmacology, Structural Aspects and Synthesis
por: Kaczor, Agnieszka A., et al.
Publicado: (2022)

The Role of Genetics in the Development and Pharmacotherapy of Depression and Its Impact on Drug Discovery
por: Zięba, Agata, et al.
Publicado: (2023)

The Role of Lipids in Allosteric Modulation of Dopamine D(2) Receptor—In Silico Study
por: Żuk, Justyna, et al.
Publicado: (2022)

Comparative molecular field analysis and molecular dynamics studies of α/β hydrolase domain containing 6 (ABHD6) inhibitors
por: Kaczor, Agnieszka A., et al.
Publicado: (2015)

N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic
por: Kaczor, Agnieszka A., et al.
Publicado: (2020)

Funnel metadynamics and behavioral studies reveal complex effect of D2AAK1 ligand on anxiety-like processes
por: Bartuzi, Damian, et al.
Publicado: (2022)

The dopamine D(2) receptor dimer and its interaction with homobivalent antagonists: homology modeling, docking and molecular dynamics
por: Kaczor, Agnieszka A., et al.
Publicado: (2016)

Experimental and Computational Structural Studies of 2,3,5-Trisubstituted and 1,2,3,5-Tetrasubstituted Indoles as Non-Competitive Antagonists of GluK1/GluK2 Receptors
por: Bartyzel, Agata, et al.
Publicado: (2022)

Molecular Interactions between Mecamylamine Enantiomers and the Transmembrane Domain of the Human α4β2 Nicotinic Receptor
por: Bondarenko, Vasyl, et al.
Publicado: (2014)

Synthesis, central nervous system activity, and structure–activity relationship of 1-aryl-6-benzyl-7-hydroxy-2,3-dihydroimidazo[1,2-a]pyrimidine-5(1H)-ones
por: Rządkowska, Marzena, et al.
Publicado: (2014)

Synthesis, Central Nervous System Activity and Structure-Activity Relationships of Novel 1-(1-Alkyl-4-aryl-4,5-dihydro-1H-imidazo)-3-substituted Urea Derivatives
por: Szacoń, Elżbieta, et al.
Publicado: (2015)

Thyroid Peroxidase Activity is Inhibited by Phenolic Compounds—Impact of Interaction
por: Habza-Kowalska, Ewa, et al.
Publicado: (2019)

Current Approaches and Tools Used in Drug Development against Parkinson’s Disease
por: Koszła, Oliwia, et al.
Publicado: (2021)

Synthesis, Structural Studies and Molecular Modelling of a Novel Imidazoline Derivative with Antifungal Activity
por: Wróbel, Tomasz M., et al.
Publicado: (2015)

Angiotensin II Type 1 Receptor Blockers Inhibit KAT II Activity in the Brain—Its Possible Clinical Applications
por: Zakrocka, Izabela, et al.
Publicado: (2017)

Applications of molecular replacement to G protein-coupled receptors
por: Kruse, Andrew C., et al.
Publicado: (2013)

Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D(2) Receptor Ligand
por: Kondej, Magda, et al.
Publicado: (2018)

Recent advances in roles of G-protein coupled receptors in intestinal intraepithelial lymphocytes
por: SUMIDA, Hayakazu
Publicado: (2020)

Some Dietary Phenolic Compounds Can Activate Thyroid Peroxidase and Inhibit Lipoxygenase-Preliminary Study in the Model Systems
por: Habza-Kowalska, Ewa, et al.
Publicado: (2021)

The pseudo-Michael reaction of 1-aryl-4,5-dihydro-1H-imidazol-2-amines with ethyl ethoxymethylenecyanoacetate
por: Kaczor, Agnieszka A., et al.
Publicado: (2013)

Synthesis and Pharmacological Evaluation of Novel 1-(1,4-Alkylaryldisubstituted-4,5-dihydro-1H-imidazo)-3-substituted Urea Derivatives
por: Szacoń, Elżbieta, et al.
Publicado: (2016)

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
por: Arias, Hugo R., et al.
Publicado: (2021)

Fractal dimension as a measure of surface roughness of G protein-coupled receptors: implications for structure and function
por: Kaczor, Agnieszka A., et al.
Publicado: (2012)

Conformation Guides Molecular Efficacy in Docking Screens of Activated β-2 Adrenergic G Protein Coupled Receptor
por: Weiss, Dahlia R., et al.
Publicado: (2013)

Xiaoxuming Decoction Regulates Vascular Function by Modulating G Protein-Coupled Receptors: A Molecular Docking Study
por: Shen, Yanjia, et al.
Publicado: (2021)

Assessment and Challenges of Ligand Docking into Comparative Models of G-Protein Coupled Receptors
por: Nguyen, Elizabeth Dong, et al.
Publicado: (2013)

Ligand Docking Methods to Recognize Allosteric Inhibitors for G-Protein-Coupled Receptors
por: Harini, K, et al.
Publicado: (2021)

Recent Advances in Molecular Docking for the Research and Discovery of Potential Marine Drugs
por: Chen, Guilin, et al.
Publicado: (2020)

Efficacy of Dabrafenib and Trametinib in a Patient with Squamous-Cell Carcinoma, with Mutation p.D594G in BRAF and p.R461* in NF1 Genes—A Case Report with Literature Review
por: Grenda, Anna, et al.
Publicado: (2023)

Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery
por: Zou, Ye, et al.
Publicado: (2019)

Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation
por: Stępnicki, Piotr, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8tqoognc2ae9htkn1e5oactdbm